Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression. - Wikidata - awgldk - TriplyDB

Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression.

Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression.

http://www.wikidata.org/entity/Q39574533

about

Human breast cancer tissues contain abundant phosphatidylcholine(36∶1) with high stearoyl-CoA desaturase-1 expression Lipid metabolic reprogramming in cancer cells Understanding Metabolomics in Biomedical Research Structure and function of biotin-dependent carboxylases Applications of mass spectrometry for cellular lipid analysis Obesity and psychotic disorders: uncovering common mechanisms through metabolomics On the future of mass-spectrometry-based lipidomics Key Players in Choline Metabolic Reprograming in Triple-Negative Breast Cancer Circulating Phospholipids as Biomarkers of Breast Cancer: A Review Advances in Lipidomics for Cancer Biomarkers Discovery A systematic comparison of copy number alterations in four types of female cancer Statin use and breast cancer survival: a nationwide cohort study from Finland Highly Selective Anti-Cancer Activity of Cholesterol-Interacting Agents Methyl-β-Cyclodextrin and Ostreolysin A/Pleurotolysin B Protein Complex on Urothelial Cancer Cells Application of desorption electrospray ionization mass spectrometry imaging in breast cancer margin analysis Assessing the barriers to image-guided drug delivery.Stronger findings from mass spectral data through multi-peak modeling Rapid evaporative ionisation mass spectrometry of electrosurgical vapours for the identification of breast pathology: towards an intelligent knife for breast cancer surgery Determination of lipidomic differences between human breast cancer and surrounding normal tissues using HILIC-HPLC/ESI-MS and multivariate data analysis.Correlation of lipidomic composition of cell lines and tissues of breast cancer patients using hydrophilic interaction liquid chromatography/electrospray ionization mass spectrometry and multivariate data analysis.Low C24-OH and C22-OH sulfatides in human renal cell carcinoma.MACC1 decreases the chemosensitivity of gastric cancer cells to oxaliplatin by regulating FASN expression.Serum Metabolomic Profiles for Breast Cancer Diagnosis, Grading and Staging by Gas Chromatography-Mass Spectrometry.Radiotherapy improves serum fatty acids and lipid profile in breast cancer.Novel nuclear localization of fatty acid synthase correlates with prostate cancer aggressiveness Significantly increased monounsaturated lipids relative to polyunsaturated lipids in six types of cancer microenvironment are observed by mass spectrometry imaging.Protein and lipid MALDI profiles classify breast cancers according to the intrinsic subtype.Impact of contralateral and ipsilateral reference tissue selection on self-referencing differential spectroscopy for breast cancer detection.Rapid, non-targeted discovery of biochemical transformation and biomarker candidates in oncovirus-infected cell lines using LAESI mass spectrometry.Allele-specific disparity in breast cancer.A joint analysis of metabolomics and genetics of breast cancer.Mass spectrometry-based quantitative metabolomics revealed a distinct lipid profile in breast cancer patients.Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue - a GC-TOFMS based metabolomics study.The lipid phenotype of breast cancer cells characterized by Raman microspectroscopy: towards a stratification of malignancy Targeting cholesterol synthesis increases chemoimmuno-sensitivity in chronic lymphocytic leukemia cells.High-resolution imaging mass spectrometry reveals detailed spatial distribution of phosphatidylinositols in human breast cancer.Phospholipid makeup of the breast adipose tissue is impacted by obesity and mammary cancer in the mouse: Results of a pilot study Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress Persistent organic pollutants and obesity: are they potential mechanisms for breast cancer promotion?Differential expression of lipid metabolism-related proteins in different breast cancer subtypes.Tissue imaging and serum lipidomic profiling for screening potential biomarkers of thyroid tumors by matrix-assisted laser desorption/ionization-Fourier transform ion cyclotron resonance mass spectrometry.

P2860

Q21090768-23CA5D23-A63D-411E-B03C-4462ACAC9286 Q26774859-FDEEF91B-9958-4946-BD42-D2314A42D83A Q26775206-6E5EC830-DB1A-4054-A41F-6DA8F140AA89 Q26851762-BE0DB9FF-6EB2-4BE4-8FB1-5A66D22C8956 Q26996187-B5BAB00A-21CD-4F7D-830B-607553CFD859 Q27011617-B73E4C7D-BB78-4C3D-9E60-581468671D3C Q27012927-3122C08E-C88F-444D-AB82-1AB28DE67CB4 Q28074613-D8DBBD0C-ED14-43A4-9921-1A606C553BD8 Q28075134-2EE29B1B-446E-4714-8C19-B9EB87E2DD3F Q28079507-37774FC0-77B0-4054-ABB1-2706C6D6DA49 Q28394747-65B2732A-0FED-4BE7-BFAB-EC475936EFE7 Q28543933-024916BC-AC84-4D6D-8B3B-7E2DF85D6B0D Q28547884-08FE4786-F19F-4530-A661-8DAE77A81807 Q30414017-0A1D8C8D-76D6-4C3B-9053-D952C0A23EDF Q30422169-B122D7BE-E039-4E30-BA39-9EAC688D411C Q30832284-0BAD5141-78BE-4F75-AF36-793C6337DD6D Q30853123-24075BFD-3290-4E3D-9901-137ECC5A82AA Q30865106-7C916D29-C280-4980-A7EA-61D9171E346A Q31143237-36E67F3C-F755-4383-853C-B568944D10FF Q31160691-2C99F976-3B51-4468-B168-92560AFE3AFD Q33673940-5FDBCE04-7039-4B4F-B960-F04CBA00A636 Q33687106-D2889FE2-B0C9-4321-B1D4-15AAFFB47B6E Q33706437-6C359984-0909-41C5-85E2-533F8C63F770 Q33978062-F166AD9C-5A29-4D47-A2F1-772AA0F5A068 Q34001479-7D774995-EFCD-4811-944B-2DF49A9F6A5B Q34059226-DA3461ED-6EA1-485F-8D9E-9BA3BDCF891F Q34082185-724C9214-6DB2-4BB0-9E0A-7A4E341BF05B Q34100300-A28B5114-8B51-425B-B8C1-9B2FF1DA5EC5 Q34107750-AB9F5B71-B118-45ED-8AF1-491369B5CED8 Q34296486-9E673657-B35C-4B09-BB25-04A0EFB84D57 Q34339067-284CA131-DD98-4027-859D-F610B8DA6FA1 Q34348061-A6D4C31B-8E02-4EE0-8BEE-C9C369D478B9 Q34451892-8D3EAD3B-73D4-40FE-B0BE-835C64017860 Q34507114-8F8CACCD-29AE-478B-8C6E-3B6EF74E44E3 Q34803382-0494EF9E-5733-4A2C-B579-D3A2EE57F499 Q34955308-7B45ABE8-A993-4670-9B8C-A149EF790FD1 Q34978574-41FAFAB2-C91D-4EAD-B8B0-D1DF84E4F45E Q35154969-B8044E53-9F4E-44B7-A01B-93468BF68EA5 Q35159467-D8D9BA37-71E2-4447-9001-2B65B46EAA2C Q35171220-CD3DF719-3C91-40EB-86CB-D81C484EE341

P2860

Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression.

http://www.wikidata.org/entity/Q39574533

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Novel theranostic opportunitie ...... in breast cancer progression.

@en

Novel theranostic opportunitie ...... in breast cancer progression.

@nl

type

label

Novel theranostic opportunitie ...... in breast cancer progression.

@en

Novel theranostic opportunitie ...... in breast cancer progression.

@nl

prefLabel

Novel theranostic opportunitie ...... in breast cancer progression.

@en

Novel theranostic opportunitie ...... in breast cancer progression.

@nl

P1433

Q39574533-09CB5BE1-97D6-4755-841C-5ECE86DD4638

P1476

Q39574533-698730E6-6F20-4C2E-8DEE-9B50DF18CDE5

P2093

Q39574533-013876E3-88CF-4099-9A33-F1CB7BA6769B

Q39574533-05F9F1FE-F619-4353-BF6E-480BEEE49F44

Q39574533-133472D4-4179-4110-8E2E-AF7870B7C0C1

Q39574533-2E794771-CCA9-437C-B825-286BC14492F1

Q39574533-3045E184-C789-4834-B64C-8226B33F0F2D

Q39574533-4045DDEE-2398-4E6F-9D7E-BACC18DC124D

Q39574533-5ED491B3-D3FE-4FD3-9463-64A1201E74D8

Q39574533-683A4820-BAA1-42EA-933E-E99D44A04B41

Q39574533-7D159B11-0738-4118-9094-0612575C8452

Q39574533-9A4F99F1-B542-4FB8-A94B-A2885DB20C6D

P304

Q39574533-A86680A1-327A-4168-BF30-5C9555D9D767

P31

Q39574533-14D8A97C-C162-444E-B995-041BF6E3B379

P356

Q39574533-08BB1392-4344-4A39-A7ED-E8A64C7AABB3

P407

Q39574533-DEF303DE-42AB-4DE3-9D46-AA91B8AAC2CC

P433

Q39574533-9DEA14BF-C48F-4852-A3D4-CCADC5B6D2EF

P478

Q39574533-3DB56134-1E5A-46BE-8B47-2F170C121097

P50

Q39574533-00FADAB7-2C43-49F6-B844-6F793AC37FE1

Q39574533-161B3303-BD01-45E9-8F9D-396DD3F0922D

Q39574533-73A60B7A-F598-4075-BB07-738D403A8735

Q39574533-772D57E1-D019-48C5-88E1-E86C872A9A50

Q39574533-9EFBEB30-626E-4EFA-94CF-C9096217B44D

Q39574533-AFAAEF78-0A7F-4690-997F-94CD21F506A7

Q39574533-C45DE12A-7644-4154-BD1A-D8B0A1B40DDF

Q39574533-DEA2AF03-A834-42FA-AEAE-281EBC992BB7

P577

Q39574533-2552D19D-5084-499A-BD62-1C1CB5F00BEA

P698

Q39574533-88DF3AB5-6F06-4109-8808-E1B2B195142E

P356

0008-5472.CAN-10-3894

P1433

Cancer Research

P1476

Novel theranostic opportunitie ...... in breast cancer progression.

@en

P2093

Berit Müller

http://www.w3.org/2001/XMLSchema#string

Christiane Richter-Ehrenstein

http://www.w3.org/2001/XMLSchema#string

Cornelia Radke

http://www.w3.org/2001/XMLSchema#string

Emilia Berg

http://www.w3.org/2001/XMLSchema#string

Heli Nygren

http://www.w3.org/2001/XMLSchema#string

Jan Budczies

http://www.w3.org/2001/XMLSchema#string

Kristiina Iljin

http://www.w3.org/2001/XMLSchema#string

Laura Lehtinen

http://www.w3.org/2001/XMLSchema#string

Laxman Yetukuri

http://www.w3.org/2001/XMLSchema#string

Marko Sysi-Aho

http://www.w3.org/2001/XMLSchema#string

P304

3236-3245

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-10-3894

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P50

Olli-Pekka Kallioniemi

Carsten Denkert

Julian L Griffin

P577

2011-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21415164

http://www.w3.org/2001/XMLSchema#string